Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H62N6O4 |
InChIKeyZNTVQLYTHZKKRD-CONSDPRKSA-N |
CAS Registry3011782-51-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Candidiasis | Preclinical | CN | 30 May 2022 |